Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Abatacept × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Myelodysplastic Syndromes 4 Lymphoma 3 Leukemia, Myeloid, Acute 3 Graft vs Host Disease 3 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Myocarditis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Arthritis 1 Anemia, Refractory 1

Interventions

efgartigimod alfa 10 rozanolixizumab 9 Prednisone 8 zilucoplan 7 Pyridostigmine Bromide 7 Cyclophosphamide 7 telitacicept 6 Tacrolimus 6 Rituximab 6 ravulizumab 5 fludarabine 5 eculizumab 5 Mycophenolic Acid 4 Hizentra 4 Steroids 3 Immunoglobulins, Intravenous 3 HBM9161 3 Data Collection 3 Azathioprine 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Blood Specimen Collection 2 tofacitinib 1 tocilizumab 1 satralizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03059888 2019-11-22

Trial of Orencia in Patients With Myasthenia Gravis

Johns Hopkins University

Phase EARLY_PHASE1 Terminated

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡